Skip to main
ZTS

Zoetis (ZTS) Stock Forecast & Price Target

Zoetis (ZTS) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 18%
Hold 55%
Sell 0%
Strong Sell 0%

Bulls say

Zoetis is poised for growth in the animal health market with a strong pipeline and a loyal customer base, despite facing competition and external challenges. Their focus on new product launches and investments in the companion animal market make them a leader in the industry, although they may encounter some headwinds from larger competitors and potential economic and political risks. Overall, ZTS's strong market share and promising R&D plans make it a favorable investment option for the long-term.

Bears say

Zoetis is a global leader in the animal health industry and has a solid market position with a strong customer base, but potential negative factors include the risk of outbreaks of infectious disease carried by animals, reliance on third parties for products and materials, and a premium valuation on the stock. There is also potential for competition in the pet dermatology market and recent challenges in the animal health end-market such as staffing shortages and inflationary pressures. However, potential opportunities for the company include the growing human-animal bond and an expanding global population driving demand for animal protein.

Zoetis (ZTS) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 18% recommend Buy, 55% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Zoetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Zoetis (ZTS) Forecast

Analysts have given Zoetis (ZTS) a Buy based on their latest research and market trends.

According to 11 analysts, Zoetis (ZTS) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $154.18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $154.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Zoetis (ZTS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.